This was a question posted on my introduction post. Just to make sure that it doesn't get out of hand with more questions, I thought I'd move the original question with my response here. I'm still trying to find out some more information and I'll post any new findings after this:
I have a question for you MM, concerning Epo. My understanding is that Epo (as opposed to Aranesp) is better absorbed by the body and therefore less is needed if it is given subcutaneously rather than into the lines during dialysis. .I live in Canada and used to dialyze at a self-care clinic so this was never an issue for me and I also used Aranesp, not Epo. However, I'm curious about your take on this. Thanks
First, let me start by saying that I am not a pharmacist. This is only my opinion.
Epogen, Aranesp, and Procrit all have the same active ingredient in them (it's called epotin alfa). They are different in the preservatives and maybe some other additives they use. Injecting epogen directly into you would be absorbed better only because you wouldn't be diluting it into the lines.
Some people also have a reaction to the different drugs (again, because of the preservatives). If you're used to taking the multi-dose version of epogen and then get switched to a single dose, you might feel a burning sensation. This is because the single dose doesn't contain the preservatives (which somehow numbs the body's reaction to epo).
I don't have much knowledge on Aranesp. but I would guess that if you could or would inject it subcutaneously it would work similar to epogen in a small amount.
I've also heard of studies about an additive that would make epo stay in the body longer and be absorbed better (thus less injections), but I can't remember off the top of my head what it was.